XBiotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4XB?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,523,64914.8%
Individual Insiders10,635,03134.9%
General Public15,329,05150.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 48.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.8%
Thomas Gut
3,914,111€10.0m0%no data
12.5%
John Simard
3,823,166€9.7m0%no data
8.65%
W. McKenzie
2,637,011€6.7m-0.61%no data
4.22%
BlackRock, Inc.
1,285,763€3.3m-0.65%no data
3.49%
The Vanguard Group, Inc.
1,062,772€2.7m-0.17%no data
1.51%
Geode Capital Management, LLC
461,230€1.2m1.47%no data
0.75%
State Street Global Advisors, Inc.
229,695€584.1k0%no data
0.69%
Northern Trust Global Investments
209,251€532.1k-1.05%no data
0.66%
Jan-Paul Waldin
200,243€509.2k0%no data
0.6%
Bridgeway Capital Management, LLC
183,664€467.1k-10.1%0.01%
0.34%
Morgan Stanley, Investment Banking and Brokerage Investments
104,797€266.5k-13.7%no data
0.33%
American Century Investment Management Inc
101,658€258.5k-18.2%no data
0.3%
BNY Asset Management
91,060€231.6k0%no data
0.27%
Millennium Management LLC
82,356€209.4k-68.8%no data
0.24%
Dimensional Fund Advisors LP
73,526€187.0k-2.14%no data
0.22%
Charles Schwab Investment Management, Inc.
67,355€171.3k15.3%no data
0.22%
Mckenzie Charitable Foundation, Endowment Arm
66,748€169.7k0%no data
0.21%
Connor, Clark & Lunn Investment Management Ltd.
65,185€165.8k-12.1%no data
0.17%
UBS Asset Management AG
51,813€131.8k11.4%no data
0.11%
Goldman Sachs Group, Investment Banking and Securities Investments
34,479€87.7k-35.8%no data
0.1%
Deutsche Asset & Wealth Management
30,338€77.2k0%no data
0.087%
Susquehanna International Group, LLP, Asset Management Arm
26,517€67.4k108%no data
0.084%
Angela Hu
25,500€64.8k0%no data
0.082%
Peter Libby
25,000€63.6k0%no data
0.082%
National Bank Investments Inc.
25,000€63.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 11:09
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

XBiotech Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaNOBLE Capital Markets, Inc.
Joseph CatanzaroPiper Sandler Companies